These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22784847)

  • 1. Thyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs?
    Shoemaker TJ; Kono T; Mariash CN; Evans-Molina C
    Endocr Pract; 2012; 18(6):954-64. PubMed ID: 22784847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes.
    Grover GJ; Mellström K; Malm J
    Curr Vasc Pharmacol; 2007 Apr; 5(2):141-54. PubMed ID: 17430219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects.
    Grover GJ; Mellstrom K; Malm J
    Cardiovasc Drug Rev; 2005; 23(2):133-48. PubMed ID: 16007230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia.
    Jakobsson T; Vedin LL; Parini P
    Drugs; 2017 Oct; 77(15):1613-1621. PubMed ID: 28865063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
    Bryzgalova G; Effendic S; Khan A; Rehnmark S; Barbounis P; Boulet J; Dong G; Singh R; Shapses S; Malm J; Webb P; Baxter JD; Grover GJ
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):262-7. PubMed ID: 18621127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Hormone Analogues: An Update.
    Zucchi R
    Thyroid; 2020 Aug; 30(8):1099-1105. PubMed ID: 32098589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists: importance of liver selectivity in drug discovery.
    Takahashi N; Asano Y; Maeda K; Watanabe N
    Biol Pharm Bull; 2014; 37(7):1103-8. PubMed ID: 24989002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.
    Saponaro F; Sestito S; Runfola M; Rapposelli S; Chiellini G
    Front Med (Lausanne); 2020; 7():331. PubMed ID: 32733906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges.
    Li L; Song Y; Shi Y; Sun L
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1602-1613. PubMed ID: 36746649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
    Erion MD; Cable EE; Ito BR; Jiang H; Fujitaki JM; Finn PD; Zhang BH; Hou J; Boyer SH; van Poelje PD; Linemeyer DL
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15490-5. PubMed ID: 17878314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs.
    Zhi J; Li F; Jiang X; Bai R
    Drug Discov Today; 2024 Jun; 29(6):104013. PubMed ID: 38705510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and structure-activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor β (TRβ) selective agonists.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Matsuzawa A; Nagano R; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2013 Feb; 21(3):592-607. PubMed ID: 23276448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac specific effects of thyroid hormone analogues.
    Danzi S; Klein I
    Horm Metab Res; 2011 Oct; 43(11):737-42. PubMed ID: 22009366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired metabolic effects of a thyroid hormone receptor beta-selective agonist in a mouse model of diet-induced obesity.
    Castillo M; Freitas BC; Rosene ML; Drigo RA; Grozovsky R; Maciel RM; Patti ME; Ribeiro MO; Bianco AC
    Thyroid; 2010 May; 20(5):545-53. PubMed ID: 20406106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis.
    Runfola M; Sestito S; Bellusci L; La Pietra V; D'Amore VM; Kowalik MA; Chiellini G; Gul S; Perra A; Columbano A; Marinelli L; Novellino E; Rapposelli S
    Eur J Med Chem; 2020 Feb; 188():112006. PubMed ID: 31931337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas.
    Columbano A; Pibiri M; Deidda M; Cossu C; Scanlan TS; Chiellini G; Muntoni S; Ledda-Columbano GM
    Endocrinology; 2006 Jul; 147(7):3211-8. PubMed ID: 16574785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sobetirome: a case history of bench-to-clinic drug discovery and development.
    Scanlan TS
    Heart Fail Rev; 2010 Mar; 15(2):177-82. PubMed ID: 19002578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.
    Filgueira CS; Nicolov E; Hood RL; Ballerini A; Garcia-Huidobro J; Lin JZ; Fraga D; Webb P; Sabek OM; Gaber AO; Phillips KJ; Grattoni A
    Int J Obes (Lond); 2016 Nov; 40(11):1776-1783. PubMed ID: 27460601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.